ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Transforming Trials: Reducing Cost and Risk
An article by Dr. Phil Birch on some strategies for transforming clinical trials.
ICON Recognised for Excellence in Vaccine Development
Article on the future of drug development and the central role that precision medicine will play in global healthcare.
Effective Sponsor-CRO Collaboration
Commentary in PharmaVOICE on effective sponsor-CRO collaboration.
Predatory Journals Are Back in the Firing Line
Learn how to spot a predatory journal with these tips from PubsHub.
Overcoming Four Challenges to Successful Rare Disease Drug Development
Article relating to overcoming challenges to greatly improve the chances for a successful rare or “orphan” drug trial.
Why a Patient's Experience with a Drug Matters
Patient reported outcomes are often the primary endpoints in FDA approved pain drugs.
PRO Instruments to Improve Endpoints for Antibacterial Drug Trials
FDA's selection of ICON to validate PRO instruments used to access clinical endpoints in antibacterial drug trials.
Cell and Gene Therapies: On Course for Commercial Success?
Article on cell and gene therapies
Market Access 2017: A European Perspective
The article discusses how UK and European regulators’ market access plans for 2017 will affect the industry.
Medtech Needs Clinical Registries for Pre- and Postmarket Data
Insights on clinical registries and generating pre- and postmarket data.